ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32463610	A210N	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
2	32463610	G212S	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
3	32463610	H213N	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
4	32463610	N218K	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
5	32463610	G230E	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
6	32463610	S229T	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
7	32463610	V228E	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
8	32463610	L226H	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
9	32463610	D210N	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
10	32463610	L248Q	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
11	32463610	G12S	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
12	32463610	Y125H	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
13	32463610	D210A	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
14	32463610	A210D	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
15	32463610	A110D	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
16	32463610	H110R	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
17	32463610	F106Y	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
18	32463610	I113V	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
19	32463610	L122I	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
20	32463610	I124V	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
21	32463610	L126F	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
22	32463610	M129I	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
23	32463610	I151L	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
24	32463610	I152L	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
25	32463610	G210N	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
26	32463610	L266H	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View
27	32463610	L28Q	LMP-1	LMP-1	Epstein-Barr Virus Infections	R L	View

Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.